MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Revenue (2019 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Revenue came in at $75.4 million in Q4 2025, up 252.33% YoY from $21.4 million in Q4 2024, and up 18281.46% on a QoQ basis from $410000.0 in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Revenue (2019 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 7 years of Revenue data on file, last reported at $75.4 million in Q4 2025.

  • Quarterly Revenue rose 252.33% year-over-year to $75.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $100.9 million (up 203.06% YoY) and the FY2025 annual result came in at $81.4 million, up 144.57% from the prior year.
  • Revenue climbed to $75.4 million in Q4 2025, from $410000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $75.4 million in Q4 2025 to a low of -$5.3 million in Q4 2022.
  • A 5-year average of $9.5 million and a median of $4.8 million in 2022 frame the typical range for Revenue.
  • Annual changes were most pronounced in 2022 — Revenue plunged 125.13% — and 2025, when it soared 1208.87%.
  • Tracing MGTX's Revenue over 5 years: stood at $21.0 million in 2021, then sank by 125.13% to -$5.3 million in 2022, then soared by 138.58% to $2.0 million in 2023, then jumped by 948.53% to $21.4 million in 2024, then jumped by 252.33% to $75.4 million in 2025.
  • The last three Revenue figures came in at $75.4 million (Q4 2025), $410000.0 (Q3 2025), and $3.7 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 145.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.71 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.29 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 674.14 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 425.49 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn 321.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 321.43 Mn
Dec 31, 2025 75.36 Mn
Sep 30, 2025 410,000.00
Jun 30, 2025 3.69 Mn
Mar 31, 2025 1.93 Mn
Dec 31, 2024 21.39 Mn
Sep 30, 2024 10.91 Mn
Jun 30, 2024 282,000.00
Mar 31, 2024 697,000.00
Dec 31, 2023 2.04 Mn
Sep 30, 2023 5.10 Mn
Jun 30, 2023 3.54 Mn
Mar 31, 2023 3.33 Mn
Dec 31, 2022 -5.29 Mn
Sep 30, 2022 4.82 Mn
Jun 30, 2022 10.76 Mn
Mar 31, 2022 5.63 Mn
Dec 31, 2021 21.04 Mn
Sep 30, 2021 6.95 Mn
Jun 30, 2021 5.12 Mn